We conducted a prospective study of an electronic clinical reminder system in an academic medical center-based human immunodeficiency virus (HIV) specialty clinic. Published performance indicators were used to examine adherence to HIV practice guidelines before and after its implementation for 1204 patients. More than 90% of patients received CD4 cell count and HIV type 1 (HIV-1) RNA level monitoring every 3-6 months during both time periods, and ∼80% of patients with a CD4 cell count nadir of ! ). HIV clinical reminders delivered at the time that HIV care is provided were associated P ! .0001 with more timely initiation of recommended practices.
Health Service (USPHS)/Infectious Diseases Society of America (IDSA) guidelines for the prevention of opportunistic infections (OIs) [1] , a set of measurable indicators of clinical performance was developed to assess how well clinicians adhere to recommendations for best practice [2] . The extent to which clinicians practice in accordance with HIV guidelines represents a measure of the quality of care provided.
In many settings, electronic medical records (EMRs) help clinicians deliver care in a more timely and efficient manner. Programming developed for the EMR can compare patient-specific clinical data with evidencebased rules to provide clinical-decision support, such as reminding clinicians about recommended care. Randomized controlled trials have shown that clinical reminders delivered at the point of care can influence physician behavior [3] [4] [5] [6] , and, in particular, they can increase the likelihood that patients receive preventive interventions [7, 8] . Reminders have been shown to improve physician performance by providing the right information at the right time [9] . Clinical reminders integrated into the EMR can be delivered as the patient is seen and readily updated to accommodate changing standards of care. Busy medical practices that treat acutely ill patients are otherwise not generally organized to support less urgent needs for systematic assessments and preventive interventions [10, 11] .
Although evidenced-based guidelines for prevention of OIs and antiretroviral treatment have been widely published [1, , little is known about how well these standards of care influence clinical practice [33] [34] [35] [36] . We conducted a prospective study of an electronic HIV clinical reminder system in an urban academic medical center-based HIV specialty clinic and applied performance indicators [2] to clinical data to evaluate practice patterns before and after implementation of the intervention.
PATIENTS AND METHODS

Study setting and providers. The University of Washington
Harborview Medical Center's HIV Clinic in Seattle, Washington, was established in 1985 and is the largest single provider of HIV care in the northwestern United States. During the study period, the clinic was staffed by experienced HIV clinicians comprising ∼33 physicians (including 10 postresidency fellows), 6 nurse practitioners, and 2 physicians' assistants. The majority of physicians have received or were receiving subspecialty training in infectious diseases. The clinic provides primary care, on-site specialty care, pharmaceutical needs, and social services for 11200 HIV-infected patients annually, most of whom obtain medications from the clinic pharmacy.
HIV clinical reminder system. In conjunction with development of the EMR for the University of Washington Academic Medical Center, which includes Harborview Medical Center, we designed an HIV disease-specific EMR enhancement as a quality-improvement effort for the Harborview HIV Clinic. This effort included introduction of processes within the clinical setting to computerize information relevant to the care of persons with HIV infection. The EMR enhancement provides clinicians with better access to patient-specific information, such as trended display of CD4 cell counts and HIV-1 RNA levels over time. Before each clinical encounter, providers receive a summary of current clinical information available in the EMR for each patient at the time of the visit, including laboratory test results and procedures, current medications, antiretroviral treatment history, and recommendations that are based on the USPHS/IDSA guidelines for the prevention of OIs [1, 18] . After a 1-month pilot test, we conducted provider education and training in the use of the HIV clinical reminder system from 1 January 1998 through 31 March 1998, and we implemented the system clinicwide on 1 April 1998.
University of Washington HIV Information System (UWHIS).
EMR systems have limited programming and processing capability to transform transactional data into longitudinal patient-based data required for analysis of clinical care and outcomes. Thus, we developed the UWHIS to integrate and process data generated during the course of routine patient care to support HIV clinical outcomes research. The UWHIS captures comprehensive clinical information for HIV-infected patients from multiple clinical and administrative computing systems, including data contained within the EMR. Automated laboratory and pharmacy information, structured clinical encounter data (such as medical diagnoses), and information collected at the time of the patient's initial visit to the clinic and through chart review, including antiretroviral treatment history, are captured.
The UWHIS database architecture uses relational tables in the Microsoft SQL Server 2000 environment. Programmingalgorithms identify all medications and dosing regimens defined by the USPHS/IDSA guidelines as appropriate for the prevention of OIs for the specific calendar period during which the medication was dispensed [1, 13, 18] . These medications include trimethoprimsulfamethoxazole, dapsone, aerosolized pentamidine, and atovaquone, to prevent Pneumocystis carinii pneumonia (PCP); rifabutin, azithromycin, and clarithromycin, to prevent Mycobacterium avium complex (MAC) infection; trimethoprim-sulfamethoxazole, dapsone plus pyrimethamine, and atovaquone, to prevent Toxoplasma gondii infection; and all antiretroviral medications. Programs are applied to pharmacy dispensing data, which include detailed information regarding the strength, dosing schedule, and quantity of medication dispensed. The Harborview clinic pharmacy dispensed medications for 96% of clinic patients during the study period.
Study patients. In this study, we examined patient-based measures to assess provider practice patterns; thus, patients were the unit of analysis. All HIV-infected patients aged у18 years who received primary continuity care at the HIV clinic were eligible for the study. Patients who first met the criteria for primary prophylaxis against MAC infection and PCP and for initial screening for T. gondii, syphilis, tuberculous disease, and cervical carcinoma during the 18-month period of 1 March 1996 through 31 August 1997 were included in the preintervention period. So as not to allow practices during pilot testing and provider training (October 1997 through March 1998) to influence the evaluation of performance in the pre-or postintervention period, patients who first met study criteria during the period of 1 April 1998 through 30 September 1999 were included in the postintervention period. To further evaluate the effect of the intervention over time, we also examined practice for a subsequent 18-month period (1 October 1999 through 31 March 2001). The study was reviewed and approved by the University of Washington institutional review board. Statistical methods. We examined practice patterns in the pre-and postintervention periods by use of performance measures for HIV care developed by Gross et al. [2] . These measures target recommendations rated as AI or AII by the IDSA/USPHS OI Prevention Guidelines Working Group [13] . The rating scheme indicates the strength of the recommendation (ranging from A ["should always be offered"] to E ["should never be offered"]) and the design of the studies supporting the indicated care (level I, randomized, controlled trials; level II, nonrandomized, controlled trials and cohort and case-control studies; and level III, expert opinion) [13] . The HIV performance indicator set measures the proportion of patients in care who undergo monitoring of CD4 cell count and HIV-1 RNA level (AI), HAART (AI), PCP prophylaxis (AI), MAC prophylaxis (AI), tuberculin skin testing (TST; AI), and cervical Papanicolaou (Pap) smears (AII) within a 60-day window of observation [2] . Because patients in our setting are reappointed for visits at 3-6-month intervals, a 90-120-day time window of observation was applied.
We examined time to receipt of primary prophylaxis against MAC infection (AI), PCP (AI), or T. gondii infection (AII) after the first decrease in the CD4 cell count to !50 cells/mm 3 , !200 cells/mm 3 (or !14%), or 100 cells/mm 3 , respectively, by KaplanMeier survival analysis [37] . All patients with a history of MAC disease, PCP, or T. gondii infection before the study period were excluded. Results before and after the intervention were compared by use of the log-rank test. Patients were observed until they received prophylaxis, were lost to follow-up, or reached the end of the observation period. Cox proportional-hazard analysis [38] was used to examine time to initiation of prophylaxis, controlling for age, sex, race, and risk factor for HIV transmission. Patients were considered to be receiving prophylaxis if they received a medication and dose recommended for prevention of OIs at the time that the prescription was dispensed and a minimum of 30 days' supply. We used logistic regression to examine the probability of having serological testing for T. gondii (AI) and a nontreponemal serology testing (rapid plasma reagin and Venereal Disease Research Laboratory; AI) performed р90 days after a patient's initial clinic visit during the pre-and postintervention period while controlling for the patient's demographic factors. Among patients who had serological test results that were negative for syphilis, we examined the probability that an annual screening test had been performed 19 months after the previous test. Patients were observed until the end of the observation period or loss to follow-up. Among female patients who averaged у1 visit to the clinic every 6 months and who were receiving care for у1 year during the pre-or postintervention period, we examined the probability of having a cervical Pap smear performed (AII). We used Student's t test to compare mean clinic visit frequency per patient by time period.
was considered to be statis-P ! .05 tically significant for all statistical tests.
RESULTS
Indications for prophylaxis and screening were met by 1204 HIV-infected patients who received primary care during the study period. The majority of study patients were white men who had had sexual contact with other men as a risk factor for HIV transmission (table 1) . Approximately one-half of the cohort was aged 30-39 years, and 80% had some form of public medical insurance. Characteristics of patients in the study were similar to those of all patients receiving care at the Harborview HIV Clinic during the study period (data not shown). Frequency of clinic visits for the study cohort averaged every 3-4 months and did not differ for pre-and postintervention periods ( ).
Performance indicators. More than 96% of patients with CD4 counts of у350 cells/mm 3 had a CD4 cell count and HIV-1 RNA level measured at least every 6 months, and ∼90% of patients with CD4 cell counts of !350 cells/mm 3 were tested every 3-4 months during both the pre-and postintervention periods (table 2). The proportion of patients who received PCP prophylaxis and HAART was also high. Of the 19% of patients with a CD4 cell count nadir of !350 cells/mm 3 who were not receiving HAART, 38% had a history of injection drug use (IDU), whereas 23% of patients who were receiving HAART had a history of IDU. The proportion of patients who received prophylaxis against MAC infection within 120 days of the first CD4 cell count of !50 cells/mm 3 increased significantly from the preintervention period (21%) to the postintervention period (49%), as did the proportion of female patients who received annual cervical carcinoma screening (from 54% to 71%). There was no significant difference in the proportion of patients who underwent TST.
Time to initiation of primary prophylaxis against OIs. We found a significant decrease in time from the first CD4 cell count of !50 cells/mm 3 until receipt of MAC prophylaxis ( ; figure 1) . After controlling for other factors, pa-P p .0004 tients had 3.84 times the relative hazard of receiving MAC prophylaxis during the postintervention period than during the preintervention period (95% CI, 1.58-9.32;
; table 3). P p .003 Median time from the first CD4 cell count of !200 cells/mm 3 (or !14%) to receipt of prophylaxis against PCP was ∼9 weeks in both the pre-and postintervention periods ( ; figure P p .1 2); results were similar in the adjusted analysis (table 3) . There were too few individuals with positive results of serological tests for T. gondii and decreases in the CD4 cell count to !100 cells/ mm 3 to determine a stable estimate of time until prophylaxis against T. gondii infection.
Time to initiation of prevention and screening. After controlling for other factors, patients who received care during the postintervention period were significantly more likely to be screened for T. gondii infection within 90 days of their initial visit (OR, 1.86; 95% CI, 1.05-3.27;
; table 3). We found P p .03 no difference in the adjusted odds of initial screening for syphilis (595 patients;
). Among patients who had had a neg-P 1 .2 ative serological test result for syphilis, those who received care during the postintervention period had 13 times the adjusted odds of receiving annual repeated screening for syphilis than did those receiving care in the preintervention period (OR, 3.71; 95% CI, 2.37-5.81; ). Female patients had 2 times the P ! .0001 adjusted odds of receiving cervical carcinoma screening during the postintervention period (OR, 2.09; 95% CI, 1.04-4.16; ), and there was no significant change in the adjusted P p .04 odds of receiving TST ( ). P 1 .2 We also examined screening provided to patients during a subsequent 18-month period that occurred 19-36 months after the intervention was implemented. These patients had one-half the odds of undergoing serological testing for T. gondii infection compared with patients who received care during the 18-month period immediately after the intervention period (OR, 0.52; 95% CI, 0.29-0.92; ), and their odds of being screened P p .03 were no different than those observed before the intervention was implemented (OR, 0.95; 95% CI, 0.58-1.57;
). This P p .9 pattern was not observed for other screening measures.
DISCUSSION
The objective of this study was to assess differences in clinical adherence to recommended screening and prophylaxis practices before and after implementation of an electronic HIV clinical reminder system based on published clinical guidelines. Physicians often fail to comply with published guidelines for clinical care [39] . This poses significant challenges for disseminating research findings and incorporating new evidence-based guidelines into clinical practice. Some strategies used to improve clinicians' knowledge and use of clinical guidelines have been more effective than others. Commonly used didactic approaches to continuing medical education have had no lasting effects on practice [9] . More-personalized physician education through tutorials, use of local opinion leaders, and performance feedback have had greater, although variable, success [40] . Even when clinicians are knowledgeable about guidelines, lack of organization and lack of access to clinical information at the time that care is provided pose major obstacles to optimal performance; needed information is often buried in the paper medical record. Clinical guidelines are more likely to contribute to good practice and sustained Adjusted hazard ratio (HR) for receipt of primary prophylaxis and adjusted odds ratio (OR) for performance of serological screening, according to selected variables. provider adherence if incorporated into a system that improves the organization of clinical information and provides reminders for indicated interventions [41] . Because this study was conducted in a clinic staffed by experienced HIV care providers, our finding of high levels of clinician adherence to most recommendations even before implementation of the clinical reminder system was not surprising and allowed little room for improvement. Despite the high level of initial syphilis screening observed before and after reminders were introduced, there was significant improvement in the rate of annual syphilis screening after the system was implemented. The level of annual cervical carcinoma screening also improved. These results suggest that clinicians were knowledgeable about the indications for screening, yet they still benefited from reminders indicating when to repeat tests. Even among experienced providers, such a system may improve care by presenting and synthesizing clinical information and guideline recommendations for efficient review. The lower level of administration of MAC prophylaxis compared with PCP prophylaxis during the preintervention period may be attributable, in part, to provider perceptions of lower effectiveness of MAC prophylaxis and the high pill burden experienced by patients during advanced stages of illness, which was mitigated during the postintervention period by patient-specific reminders about MAC prophylaxis presented as optimal care.
Assessment of good practice should not only include the proportion of patients receiving recommended treatment, but it should also include a measure of the timeliness with which treatment is provided. Delaying the implementation of recommended HIV care may significantly affect a patient's clinical outcome. A previous study of provider adherence to OIprevention guidelines reported high levels of compliance but observed patients up to several years after the time that care was indicated [33] . Longer periods of observation allow more time for providing recommended care. For example, extending the time of observation in our study by 41 days increased the proportion of patients receiving PCP prophylaxis from 86% to 90%, and further extension resulted in even higher levels of performance. In this study, we demonstrated improvement in the proportion of patients receiving recommended care-and, more importantly, in earlier recognition and initiation of treatment. Because physicians with greater HIV experience provide recommended care in a more timely way [36] , the impact of such a system would likely be magnified in settings in which clinicians have less experience in the care of persons with HIV infection. Performance indicators measure the average level of practice for a population and do not account for differences across subsets of patients. We observed a relatively high proportion of patients receiving HAART. Among patients who were not receiving HAART, nearly one-half had a history of IDU. Substance-using patients have been found to initiate HAART significantly later in the course of disease, especially if they are not receiving treatment for substance use [42] . Although onethird of our patient population had substance use problems, more than two-thirds of patients with a history of IDU were receiving HAART. Some patients may be offered HAART but elect not to initiate treatment, and others may have comorbidities, such as mental health problems, that may influence initiation of treatment. Our results may be generalized to settings providing care to patients with similar characteristics.
Performance indicators have less-than-perfect sensitivity and specificity in classifying care, in view of limitations inherent in defining appropriate subsets of patients and observation periods for examination, and in failure of documentation and retrieval of information. Therefore, target levels for performance are rarely set at 100%. All clinical settings present difficulties in obtaining information required to assess performance. Documentation of TST is often incomplete, which may account in part for our finding relatively low levels of TST. Because the degree of underreporting may differ from setting to setting, the proportion of patients who meet criteria across settings may not be comparable. Thus, indicators are most appropriately used for comparing changes in performance applied to the same population in a given setting over time.
We conducted a prospective time-series evaluation of our reminder system, and, therefore, we were unable to control for secular trends in practice patterns that may have occurred during the study period. Thus, our results may also reflect increasing provider awareness of new guidelines. However, the fact that screening for T. gondii infection improved during the 18 months immediately after implementation of the intervention, but that it returned to preintervention levels 19-36 months after implementation, suggests that the reminder system effect on clinical performance waned over time. Interventions aimed at changing behavior often lead to improved behavior immediately after implementation, but that behavior declines over time. Clinic visit frequency remained stable during the study period. Thus, higher levels of prevention activities observed in the postintervention period were not attributable to patients attending the clinic more frequently. Because we examined the initiation of primary prophylaxis against MAC infection and PCP, changes in guidelines that allowed for discontinuation of prophylaxis among patients with sustained CD4 cell count increases in response to antiretroviral treatment did not apply. We have instituted efforts to improve knowledge of guidelines and to provide feedback to clinicians regarding adherence to recommended practice.
In conclusion, our EMR-based reminder system provides an effective way to deliver and rapidly revise evidenced-based guidelines for the care of patients with HIV infection. Our system uses routinely collected clinical data and therefore could be generally applicable to other settings as computerization of medical information and EMRs are introduced. Programming emphasis should be on user-friendly collection and display of medically relevant information in a context that emphasizes adherence to clinical guidelines as optimal patient care. Implementation of an HIV clinical reminder system in a setting with less experienced HIV providers might be associated with improvements of even greater magnitude.
